9:30 am

As reimbursement and health care reform continues to reward quality and value, pharmaceutical manufacturers have an opportunity to create innovative risk sharing strategies to inform value based contracts. As payment is contingent on outcomes, ensuring patient engagement for adherence is fundamental to generating the outcome measures and metrics needed to establish value-based arrangements. As part of this workshop attendees will have the opportunity to get granular and have a hands-on discussion on the importance of incorporating patient insights into value-based arrangements and ways to drive innovation, ensure transparency, and maximize opportunities to foster collaborative partnerships in value-based arrangements.

  • Discuss the health care payment evolution and the range of innovative, value-based contracting models
  • Discuss how manufacturers can ensure patient adherence on a prescription drug within legal and compliance parameters
  • Examine different types of adherence data necessary to roll out a successful value-based arrangement
  • Explore data & metrics required by Payers when entering into value-based arrangements
  • Understand how to develop risk sharing strategies through collaborative stakeholder partnerships
Thomas Hubbard
Thomas Hubbard
Vice President policy and research
PHRMA

Boxiong Tang
Boxiong Tang
Senior Director, Global Medical Affairs
Teva

9:30 am

Prescription assistance and access programs have emerged in an effort to help patients who lack health insurance or prescription drug coverage obtain the medications they need. As financial and patient affordability barriers continue to be an influencing factor on why patients do not start on therapies, pharma is tasked with developing patient assistance programs that provide access to those in financial need. Developing an effective patient assistance program increases speed to therapy, supplies patient data and analytics and expands access for those who require high cost specialty drugs. Understand how to develop an effective patient assistance and access program to improve the patient experience.

  • Gain insight into patient decision making and opportunities to provide patient access and support programs
  • Understand how to anticipate the patient insurance and access challenges
  • Evaluate data from the patient journey to inform a value based support program
  • Design an effective support program to ensure patient adherence, access and speed to therapy, and affordability
  • Avoid interruptions in speed to therapy and design support solutions for uninsured and underinsured patients
  • Help patients gain a holistic view of their coverage and benefits to overcome barriers to access
Katherine Sharpe
Katherine Sharpe
Senior Vice President, President and care giver support
American Cancer Society

* There is a 15 minute coffee and networking break from 10:45 am - 11:00 am

1:30 pm

There will be a 15 minute break from 2:45 PM – 3:00 PM

The secret ingredient to designing an innovative patient experience and improved adherence lies with developing products and services that create meaningful patient experiences. Design Thinking is a novel approach to capturing the end user experience and applying it to program design, technologies and business models. Applying design thinking requires a shift in how pharma approaches the patient journey, applying empathy to address the financial, support, and adherence challenges patients face along the continuum of care. Applying the Design Thinking approach helps to shed light on the pain points patients face along the treatment journey and challenges pharma to discover solutions to ensure patients are disciplined about medication in-take and adherence, inspiring a behavioral change. Developing gadgets, smart pill packs and innovative program design are all ways pharma can leverage Design Thinking to improve adherence and engagement. Through the course of this workshop attendees will understand the different stages of Design Thinking and how it can be used and applied to improve adherence program design to redesign the patient experience.

  • Discover the different stages to implementing a Design Thinking approach and how best to leverage Design Thinking to improve adherence and engagement
  • Develop patient centric adherence programs through Design Thinking to alleviate the pain points along the patient journey
  • Understand how to develop a strategic design process to improve the quality of life for patients and enhance health outcomes
Amy Bucher
Amy Bucher
Behavior Change Design Director
Mad*Pow

Shawn R. Nason
Shawn R. Nason
Chief Operating Officer, Population Health and Healthways Innovation Living Lab
Healthways